Researchers at the University of Pittsburgh have found special high-risk cells in the fallopian tubes that may trigger ...

AstraZeneca has agreed to purchase Belgium-based EsoBiotec for up to $1 billion. The acquisition is aimed at enhancing ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically relevant approach to determine clonal tumor mutation ...

This therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and significantly reducing costs, thus enhancing accessibility in India and ...

25, 2024 — Chromosomal instability plays a crucial role in the progression of cancer: it shapes the properties of tumor cells and drives the development of therapy resistance. Scientists used ...

A new study from the University of Toronto has found that a low-carbohydrate diet may increase the risk of colorectal cancer ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...

Metastasis is responsible for the majority of cancer-related deaths, as cancer cells break away from the original tumour and ...

(Reuters) -Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said ...

Researchers have discovered the likely origin of a deadly form of ovarian cancer, offering new hope for early detection and ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer ...